Figure 3.
Powder X-ray Diffractometry XRD of (A) pure drug, (B) formula with glucose as a carrier (FN1), (C) formula with maltodextrin as a carrier (FN2), and (D) formula with mannitol as a carrier (FN3).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.